Literature DB >> 9087364

Supratentorial diffuse astrocytic tumours: proposal of an MRI classification.

A Pierallini1, M Bonamini, A Bozzao, P Pantano, D D Stefano, E Ferone, M Raguso, C Bosman, L Bozzao.   

Abstract

The aim of this study was to obtain an MRI severity-related classification of diffuse astrocytic tumours able to integrate the histological data in the grading of such tumours. We studied presurgical MR images of 91 patients with a histological diagnosis of astrocytoma, anaplastic astrocytoma and glioblastoma. A score ranging from 1 to 3 was assigned by two independent readers to each of the following MR features: oedema, mass effect, contrast enhancement, borders, signal homogeneity, necrosis, haemorrhage and flow void. Statistical analysis showed significant differences in the mean MRI scores between the three histological grades. Contrast enhancement was found to be the best predictor of the histological grade followed by necrosis, signal homogeneity and border scores. This classification represents a simple and reproducible means of carefully evaluating some macroscopic characteristics of these tumours. It could be used to integrate histological data especially in cases in which tissue sampling defects may affect the validity of this examination.

Entities:  

Mesh:

Year:  1997        PMID: 9087364     DOI: 10.1007/s003300050173

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  13 in total

Review 1.  Conventional MRI evaluation of gliomas.

Authors:  N Upadhyay; A D Waldman
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study.

Authors:  Johann-Martin Hempel; Cornelia Brendle; Benjamin Bender; Georg Bier; Marco Skardelly; Irina Gepfner-Tuma; Franziska Eckert; Ulrike Ernemann; Jens Schittenhelm
Journal:  J Neurooncol       Date:  2018-04-17       Impact factor: 4.130

3.  Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.

Authors:  Philip Jonsson; Andrew L Lin; Robert J Young; Natalie M DiStefano; David M Hyman; Bob T Li; Michael F Berger; Ahmet Zehir; Marc Ladanyi; David B Solit; Angela G Arnold; Zsofia K Stadler; Diana Mandelker; Michael E Goldberg; Juliann Chmielecki; Maryam Pourmaleki; Shahiba Q Ogilvie; Shweta S Chavan; Andrew T McKeown; Malbora Manne; Allison Hyde; Kathryn Beal; T Jonathan Yang; Craig P Nolan; Elena Pentsova; Antonio Omuro; Igor T Gavrilovic; Thomas J Kaley; Eli L Diamond; Jacqueline B Stone; Christian Grommes; Adrienne Boire; Mariza Daras; Anna F Piotrowski; Alexandra M Miller; Philip H Gutin; Timothy A Chan; Viviane S Tabar; Cameron W Brennan; Marc Rosenblum; Lisa M DeAngelis; Ingo K Mellinghoff; Barry S Taylor
Journal:  Clin Cancer Res       Date:  2019-07-01       Impact factor: 12.531

4.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

5.  Non-enhancing de novo glioblastoma: report of two cases.

Authors:  Aaron A Cohen-Gadol; Michael L DiLuna; Sergei I Bannykh; Joseph M Piepmeier; Dennis D Spencer
Journal:  Neurosurg Rev       Date:  2004-07-28       Impact factor: 3.042

6.  Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient.

Authors:  E J Lee; S K Lee; R Agid; J M Bae; A Keller; K Terbrugge
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-21       Impact factor: 3.825

7.  Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.

Authors:  Osamu Togao; Akio Hiwatashi; Koji Yamashita; Kazufumi Kikuchi; Jochen Keupp; Koji Yoshimoto; Daisuke Kuga; Masami Yoneyama; Satoshi O Suzuki; Toru Iwaki; Masaya Takahashi; Koji Iihara; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-03-22       Impact factor: 5.315

8.  Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.

Authors:  S C Thust; S Hassanein; S Bisdas; J H Rees; H Hyare; J A Maynard; S Brandner; C Tur; H R Jäger; T A Yousry; L Mancini
Journal:  Eur Radiol       Date:  2018-03-23       Impact factor: 5.315

9.  Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.

Authors:  Xiao-Wei Kang; Yi-Bin Xi; Ting-Ting Liu; Ning Wang; Yuan-Qiang Zhu; Xing-Rui Wang; Fan Guo
Journal:  BMC Med Imaging       Date:  2020-05-14       Impact factor: 1.930

10.  Clinicopathologic Features and Early Surgical Outcome of Astrocytomas in Eldoret, Kenya.

Authors:  Clifford C Mwita; Florentius Koech; Titus Sisenda; Kirtika Patel; Benson Macharia; Devendra Rahangdale
Journal:  J Neurosci Rural Pract       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.